Michael Crescenzi, MBA
Vice President, Strategy & Business Development
Michael Crescenzi is the Vice President of Strategy and Business Development at Sonata Therapeutics. Michael brings over 30 years of biopharma experience to Sonata, in strategy, business development, operations and commercial roles within management consulting, global pharma, specialty pharma and start-up biotech environments. At Sonata, Michael leads the strategic and business development operations to support the company’s growth and evolution.
Michael was previously Vice President of Strategy and Operations at Selenity Therapeutics, where he developed the strategy and processes for R&D target selection, asset and indication prioritization and clinical trial planning. Prior to this role, Michael served as Vice President of Commercial Operations at Viamet Pharmaceutics and led the Global IVIG franchise at Talecris Biotherapeutics/Grifols.
Michael received his B.S. in Biology from Penn State University and his MBA from the University of Michigan.